Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis

Eur J Dermatol. 2013 Apr 1;23(2):273-4. doi: 10.1684/ejd.2013.1929.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Rituximab
  • Scleroderma, Localized / complications
  • Scleroderma, Localized / drug therapy*

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Immunoglobulin G
  • Immunologic Factors
  • Receptors, Tumor Necrosis Factor
  • Rituximab
  • Etanercept